Advertisement
Screener

LivaNova PLC (LIVN) Impairment of Intangible Assets (Excluding Goodwill)

2.3 / 5 stars · 53/116 Roast Me

LivaNova PLC Impairment of Intangible Assets (Excluding Goodwill)

LivaNova PLC (LIVN) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2023-02-27

  • LivaNova PLC impairment of intangible assets (excluding goodwill) for the quarter ending 2020-12-31 was $6.76M, a 92.40% decline year-over-year.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for the quarter ending 2020-09-30 was $0.00.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for the quarter ending 2019-12-31 was $89.00M, a 15596.65% increase year-over-year.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for fiscal 2022 was $0.00.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for fiscal 2020 was $6.76M, a 95.26% decline from fiscal 2019.
  • LivaNova PLC impairment of intangible assets (excluding goodwill) for fiscal 2019 was $142.52M, a 25035.27% increase from fiscal 2018.
Period endImpairment of Intangible Assets (Excluding Goodwill) 1 monthImpairment of Intangible Assets (Excluding Goodwill) 3 monthImpairment of Intangible Assets (Excluding Goodwill) 6 monthImpairment of Intangible Assets (Excluding Goodwill) 9 monthImpairment of Intangible Assets (Excluding Goodwill) 12 monthImpairment of Intangible Assets (Excluding Goodwill) 12 month as first filed
2022-12-31$0.00
10-K · filed 2023-02-27
2021-12-31$0.00
10-K · filed 2023-02-27
2020-12-31$6.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$6.76M
derived: sum of 2 quarters · filed 2023-02-27
$6.76M
derived: sum of 3 quarters · filed 2023-02-27
$6.76M
10-K · filed 2023-02-27
2020-09-30$0.00
10-Q · filed 2020-10-29
$0.00
derived: sum of 2 quarters · filed 2020-10-29
$0.00
10-Q · filed 2020-10-29
2020-06-30$0.00
10-Q · filed 2020-07-29
$0.00
10-Q · filed 2020-07-29
2019-12-31$89.00M
10-K · filed 2020-03-02
$89.00M
derived: sum of 2 quarters · filed 2020-10-29
$139.29M
derived: sum of 3 quarters · filed 2020-10-29
$142.52M
10-K · filed 2022-03-01
$139.29M
10-K · filed 2020-03-02
2019-11-30$89.00M
10-K · filed 2022-03-01
2019-09-30$0.00
10-Q · filed 2020-10-29
$50.30M
derived: sum of 2 quarters · filed 2020-10-29
$50.30M
10-Q · filed 2020-10-29
2019-06-30$50.30M
10-Q · filed 2020-07-29
$50.30M
10-Q · filed 2020-07-29
2018-12-31$567.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$567.00K
derived: sum of 2 quarters · filed 2021-03-01
$567.00K
derived: sum of 3 quarters · filed 2021-03-01
$567.00K
10-K · filed 2021-03-01
$0.00
10-K · filed 2020-03-02
2018-09-30$0.00
10-Q · filed 2019-10-30
$0.00
derived: sum of 2 quarters · filed 2019-10-30
$0.00
10-Q · filed 2019-10-30
2018-06-30$0.00
10-Q · filed 2019-07-31
$0.00
10-Q · filed 2019-07-31
2017-12-31$0.00
10-K · filed 2020-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Integer Holdings Corp (ITGR)United States$4.289B25.17
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
Axogen, Inc. (AXGN)United States$2.329B-73.83
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53